fructosamine has been researched along with thiazoles in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akanuma, Y; Iwamoto, Y; Kajinuma, H; Kasuga, M; Kosaka, K; Kuzuya, T; Shigeta, Y; Takebe, K; Yamanouchi, T; Yoshida, S | 1 |
Aufricht, C; Hayde, M; Höger, H; Lubec, B; Lubec, G; Mallinger, WR; Rokitansky, A; Wagner, U | 1 |
Beck-Nielsen, H; Berthezene, F; Boulton, AJ; Donoghue, S; Kumar, S; Lettis, S; Muggeo, M; Persson, B; Spinas, GA; Stewart-Long, P | 1 |
Kruszynska, YT; Mulford, MI; Olefsky, JM; Yu, JG | 1 |
Gomis, R; Jones, NP; Patwardhan, RN; Squatrito, S; Wolffenbuttel, BH | 1 |
Cole, ST; Freed, MI; Patwardhan, R; Rappaport, EB; Raskin, P; Yan, Y | 1 |
Deacon, LF; Jones, NP; Nolan, JJ; Patwardhan, R | 1 |
Anderson, RJ; Patel, J; Rappaport, EB | 1 |
Brant, BP; Garvey, WT; Kennedy, A; Rogers, NL; Wallace, P; Willi, SM | 1 |
7 trial(s) available for fructosamine and thiazoles
Article | Year |
---|---|
A pilot clinical trial of a new oral hypoglycemic agent, CS-045, in patients with non-insulin dependent diabetes mellitus.
Topics: Biomarkers; Blood Glucose; Body Mass Index; Chromans; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pilot Projects; Thiazoles; Thiazolidinediones; Troglitazone | 1991 |
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Chromans; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Fatty Acids, Nonesterified; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Leukocyte Count; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Neutrophils; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1996 |
A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
Topics: Blood Glucose; Body Weight; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromans; Circadian Rhythm; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fatty Acids, Nonesterified; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Male; Metformin; Middle Aged; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1999 |
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Safety; Thiazoles; Thiazolidinediones; Triglycerides | 2000 |
Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Eating; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors | 2000 |
Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Europe; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Placebos; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors | 2000 |
Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Body Weight; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Glycated Hemoglobin; Humans; Insulin; Lipids; Male; Middle Aged; Placebos; Rosiglitazone; Thiazoles; Thiazolidinediones | 1999 |
2 other study(ies) available for fructosamine and thiazoles
Article | Year |
---|---|
Thiaproline reduces glomerular basement membrane thickness and collagen accumulation in the db/db mouse.
Topics: Animals; Antioxidants; Basement Membrane; Blood Glucose; Collagen; Diabetic Nephropathies; Disease Models, Animal; Female; Fructosamine; Hexosamines; Kidney; Kidney Glomerulus; Mice; Mice, Inbred Strains; Organ Size; Solubility; Thiazoles; Thiazolidines | 1994 |
Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.
Topics: Administration, Oral; Adult; Biomarkers; Blood Glucose; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Glucocorticoids; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Leptin; Middle Aged; Prednisone; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |